Physis Capital
Latest, 10 Sept: Theater raises ₹75 crore Series A to accelerate Tier 1 and 2 offline expansion.
Newest on Physis Capital
What we know
From 3 stories, the newest dated 10 Sept 2026. Summary written 15 Oct 2026.
Physis Capital is an investor that appears in Indian retail funding news as the lead investor in a proposed round for Jewelbox, a D2C lab-grown diamond brand. [1] source: Inc42 Inc42 reported in July 2026 that Jewelbox was in advanced talks to raise ₹50 Cr in a round led by Physis Capital. [1] source: Inc42
The round was put at ₹50 Cr, or $5.2 Mn, at a valuation of about ₹300 Cr, or $31 Mn post-money. [1] source: Inc42 Jewelbox plans to use the money to expand its retail stores in Delhi, Bengaluru, Chandigarh and Bhubaneshwar. [1] source: Inc42 The same report lists a prior Jewelbox round of $3.3 Mn. [1] source: Inc42 Other brands named in that report are Aukera, Lucira, Titan Beyon, Trent Pome and V3 Ventures. [1] source: Inc42
Other retail funding rounds reported around the same time had different lead investors. Theater raised a ₹75 crore Series A led by Niveshaay in September 2026 to expand offline retail across Tier 1 and Tier 2 cities. [2] source: Entrackr LISSUN raised ₹48 Cr in a Series A led by Colossa Ventures in August 2026 to grow its Sunshine therapy-centre network from 25 to 50 centres. [3] source: Inc42
Physis Capital has appeared in 3 distinct RetailIntel stories between Jul 2026 and Sept 2026, most often under omni channel, retail brand and store opening and most frequently linked to Mumbai, Bengaluru and Bhubaneshwar.
Brands most often mentioned alongside Physis Capital
Aukera, Colossa Ventures, Jewelbox, LISSUN, Lucira, MyDesignation.
Most-cited sources on Physis Capital
Inc42 (2 stories) and Entrackr (1 story).